Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, deep venous thrombosis; EMR, electronic medical record; LMWH, low molecular weight heparin; PE, pulmonary emboli; VTE, venous thromboembolism
مقالات ISI LMWH، هپارین با وزن مولکولی کم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: LMWH، هپارین با وزن مولکولی کم; LMWH, low molecular weight heparin; CLP, becal ligation and puncture; NS, normal saline; MPO, myeloperoxidase; NF-κB, nuclear factor-kappa B; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; HMGB1, high mobility group box 1; ICAM-1, intercellular ad
Keywords: LMWH، هپارین با وزن مولکولی کم; BCBSM/BCN, Blue Cross Blue Shield of Michigan and Blue Care Network; CQI, collaborative quality initiative; LMWH, low molecular weight heparin; MTQIP, Michigan Trauma Quality Improvement Program; PI, performance improvement; VTE, venous thromboembolism
Keywords: LMWH، هپارین با وزن مولکولی کم; CRP, C-reactive protein; CT, Computer Tomography; ERCP, Endoscopic Retrograde Cholangiopancreaticography; IPP, Proton Pump Inhibitor; IU, International Units; LMWH, Low molecular weight heparin; MODS, Multiple Organ Dysfunction Syndrome; MOF, Multiple Org
Keywords: LMWH، هپارین با وزن مولکولی کم; Deep vein thrombosis; Perioperative thromboprophylaxis; Pulmonary embolismDVT, deep vein thrombosis; LMWH, low molecular weight heparin; PE, pulmTonary embolism; UFH, unfractionated heparin; US, ultrasound; VKA, vitamin K anatagonist; VTE, venous thromboe
Keywords: LMWH، هپارین با وزن مولکولی کم; VTE, venous thromboembolism; LMWH, low molecular weight heparin; DVT, deep vein thrombosis; PE, pulmonary embolism; ACCP, American College of Chest PhysiciansVenous thromboembolism hospitalization; Prophylaxis; Heparin; Low molecular weight; Hemorrhage
Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, deep venous thrombosis; ImiD, immunomodulatory drug (thalidomide and analogues); LMWH, low molecular weight heparin; NOAC, new oral anticoagulant (e.g. dabigatran, rivaroxaban, apixaban, etc.); PE, pulmonary embolism; VKA, vitamin K antagonist (warfa
Photochemical depolymerisation of dermatan sulfate and analysis of the generated oligosaccharides
Keywords: LMWH، هپارین با وزن مولکولی کم; GAGs, glycosaminoglycans; LMWH, low molecular weight heparin; DS, dermatan sulfate; GalNAc, N-acetylgalactosamine; IdoA, iduronic Acid; HSQC, heteronuclear single quantum coherence; TOCSY, total correlation spectroscopy; HMBC, heteronuclear multiple bond
Preoperative Chemoprophylaxis Is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism
Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, deep venous thrombosis; GMT, gastric and mixed tumor service; HITT, heparin-induced thrombocytopenia; HPB, hepatopancreaticobiliary service; LMWH, low molecular weight heparin; PE, pulmonary embolism; QI, quality improvement; SSE, surgical secondary
Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper
Keywords: LMWH، هپارین با وزن مولکولی کم; urologic surgical procedures; practice guideline; anticoagulants; platelet aggregation inhibitors; thromboembolismAC, anticoagulant; AP, antiplatelet; INR, international normalized ratio; LMWH, low molecular weight heparin; NOAC, novel oral anticoagulant
Insights Into Onco-Cardiology : Atrial Fibrillation in Cancer
Keywords: LMWH، هپارین با وزن مولکولی کم; antithrombotic therapy; atrial fibrillation; cancer; chemotherapy; warfarinAF, atrial fibrillation; CRP, C-reactive protein; HR, hazard ratio; LMWH, low molecular weight heparin; NT-proBNP, N-terminal pro–B-type natriuretic peptide
Familiarity and Self-Reported Compliance with American Urological Association Best Practice Recommendations for Use of Thromboembolic Prophylaxis among American Urological Association Members
Keywords: LMWH، هپارین با وزن مولکولی کم; prevention and control; heparin; practice guidelines as topic; societies, medical; thromboembolismAUA, American Urological Association; BPS, Best Practice Statement; DVT, deep vein thrombosis; LMWH, low molecular weight heparin; PTE, pulmonary thromboembo
Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
Keywords: LMWH، هپارین با وزن مولکولی کم; ACT, activated clotting time; AF, atrial fibrillation; CI, confidence interval; INR, international normalized ratio; LMWH, low molecular weight heparin; OR, odds ratio; PV, pulmonary vein; RFA, radiofrequency catheter ablation; TEE, transesophageal echoca
Venous thromboembolism prophylaxis in the pediatric trauma population
Keywords: LMWH، هپارین با وزن مولکولی کم; CVC, central venous catheter; DVT, deep venous thrombosis; ICU, intensive care unit; IPC, intermittent pneumatic compression; ISS, injury severity score; KID, Kids’ Inpatient Database; LE, lower extremity; LMWH, low molecular weight heparin; NPTR, Nationa
Clinical Impact of a Value-Based Decision: A Surgical Case Study
Keywords: LMWH، هپارین با وزن مولکولی کم; BP, best practice; C/D, cost per dose; DVT, deep venous thrombophlebitis; LMWH, low molecular weight heparin; OR, operating room; PE, pulmonary embolism; SCD, sequential compression device; UFH, unfractionated heparin; VBA, value-based analysis; VPMA, Vic
Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia
Keywords: LMWH، هپارین با وزن مولکولی کم; CML, chronic myelogenous leukemia; M, male; F, female; Hgb, hemoglobin; RBC, red blood cells; WBC, white blood cells; Plt, platelet; RT PCR, real-time polymerase chain reaction; LMWH, low molecular weight heparin; NSAID, nonsterod antiinflammatory drug; H
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting
Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, deep vein thrombosis; VTE, venous thromboembolism; dDVT, distal deep vein thrombosis; US, ultrasonography; PE, pulmonary embolism; LMWH, low molecular weight heparin; LDM, low degree of mobility; HDM, high degree of mobility; NPV, negative predictive
Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats
Keywords: LMWH، هپارین با وزن مولکولی کم; FXa, factor Xa; ED50, dose required for 50% inhibition of thrombus formation; BT2, dose required to double bleeding time; LMWH, low molecular weight heparin; PT, prothrombin time; APTT, activated partial thromboplastin time; SEM, standard error of meanOra
Fatal pulmonary thromboembolism. A retrospective autopsy study: Searching for genetic thrombophilias (Factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus
Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, Deep vein thrombosis; FII, factor II; FV, factor V; LMWH, low molecular weight heparin; PE, pulmonary embolism; PTE, pulmonary thromboembolism; UFH, unfractioned heparin; VTE, venous thromboembolismAcquired risk factors; Autopsy study; Factor V Leide
Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro
Keywords: LMWH، هپارین با وزن مولکولی کم; TF, tissue factor; TF-MV, human TF-rich microvesicles; pTF, TF-MV from human placenta; rTF, TF-MV from recombinant origin; PRP, platelet-rich plasma; LMWH, low molecular weight heparin; Col, collagen; % CS, percentage of surface covered by platelets vs. t
Studies on the effects of heparin products on pregnancy-associated plasma protein A
Keywords: LMWH، هپارین با وزن مولکولی کم; ACS, acute coronary syndrome; GAG, glucosaminoglycan; LMWH, low molecular weight heparin; PAPP-A, Pregnancy-associated plasma protein A; PCI, percutaneous coronary intervention; proMBP, the proform of eosinophil major basic protein; UFH, unfractionated he
Compliance of antithrombotic management at a tertiary paediatric hospital with international guidelines: A 100-Day audit
Keywords: LMWH، هپارین با وزن مولکولی کم; ACCP, American College of Chest Physicians; BMT, Bone Marrow Transplant; CVL, Central Venous Line; DVT, Deep Vein Thrombosis; LMWH, Low Molecular Weight Heparin; PE, Pulmonary Embolism; PICU, Pediatric Intensive Care Unit; RCH, Royal Children's Hospital;
Pediatric Venous and Arterial Noncerebral Thromboembolism in Denmark: A Nationwide Population-Based Study
Keywords: LMWH، هپارین با وزن مولکولی کم; CT, Computed tomography; CVL, Central venous line; DVT, Deep vein thrombosis; IR, Incidence rate; LMWH, Low molecular weight heparin; MI, Myocardial infarction; MRI, Magnetic resonance imaging; OCP, Oral contraceptive pill; PE, Pulmonary embolism; PTS, Po
Validation of the Caprini Risk Assessment Model in Plastic and Reconstructive Surgery Patients
Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, deep venous thrombosis; HR, hazard ratio; LMWH, low molecular weight heparin; OR, odds ratio; PE, pulmonary embolism; RAM, risk assessment model; VTE, venous thromboembolism; VTEPS, Venous Thromboembolism Prevention Study
Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB
Keywords: LMWH، هپارین با وزن مولکولی کم; TF, tissue factor; LMWH, low molecular weight heparin; NFκB, nuclear factor κB; EGF, epidermal growth factor; bFGF, basic fibroblast growth factor; VEGF, vascular endothelial growth factorTissue factor; Low molecular weight heparin; NFκB; Growth factor re
Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes
Keywords: LMWH، هپارین با وزن مولکولی کم; LMWH, low molecular weight heparin; PKCa, protein kinase C alpha; JNK, c-Jun N-terminal kinaseLow molecular weight heparin; Melanoma cell adhesion; Migration; Cell signaling; PKC alpha; JNK
Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients
Keywords: LMWH، هپارین با وزن مولکولی کم; VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; LMWH, low molecular weight heparin; BMI, body mass index; FDA, federal drug administration; MDRD, modification of diet in renal disease; IRB, institutional review board; IU, i
Incidental venous thromboembolism in cancer patients: prevalence and consequence
Keywords: LMWH، هپارین با وزن مولکولی کم; CI, confidence interval; CT, computed tomography; DVT, deep vein thrombosis; LMWH, low molecular weight heparin; PE, pulmonary embolism; VTE, venous thromboembolismvenous thromboembolism; incidental finding; cancer; treatment
Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma
Keywords: LMWH، هپارین با وزن مولکولی کم; PMBCL, Primary mediastinal large B-cell lymphoma; VTE, Venous thromboembolism; CVC, Central venous catheter; NHL, Non Hodgkin's lymphoma; DLBCL, Diffuse large B-cell lymphoma; SVCS, Syndrome venae cava superior; LMWH, Low molecular weight heparin; DVT, De
Antithrombotic efficacy of an oral low molecular weight heparin conjugated with deoxycholic asset on microsurgical anastomosis in rats
Keywords: LMWH، هپارین با وزن مولکولی کم; LMWH, Low molecular weight heparin; DOCA, Deoxycholic acid; SEM, Scanning Electron Microscope; DMSO, Dimethyl sulfoxide; DMF, Dimethyl formamideMicrovascular surgery; Oral heparin derivative; Vessel injury; Thrombus
Predictive value of thrombopath determination in women with infertility and pregnancy complications
Keywords: LMWH، هپارین با وزن مولکولی کم; ThP, ThromboPath; RPL, recurrent pregnancy loss; PTHR, prothrombin; MTHFR, methylenetetrahydrofolate reductase; PC, protein C; PS, protein S; LMWH, low molecular weight heparin; ACCP, American College of Chest Physicians; APCR, activated protein C resista
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: A randomised controlled trial in healthy elderly adults
Keywords: LMWH، هپارین با وزن مولکولی کم; aPTT, activated partial thromboplastin time; anti-FXa, anti-FXa activity; CD40L, soluble CD40 ligand; EMP, endothelial cell-derived microparticles; ETP, endogenous thrombin potential; F1 + 2, prothrombin fragment 1 + 2; LMWH, low molecular weight heparin;
French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)
Keywords: LMWH، هپارین با وزن مولکولی کم; AF, non-valvular atrial fibrillation; INR, International Normalized Ratio; LMWH, low molecular weight heparin; PCC, prothrombin complexe concentrate; UFH, unfractionned heparin; VKA, vitamin K antagonist; VTE, In patients with venous thromboembolic diseas
Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction
Keywords: LMWH، هپارین با وزن مولکولی کم; aspirin; clopidogrel; platelets; thrombolysis; acute coronary syndromeACS, acute coronary syndrome; ADP, adenosine diphosphate; CI, confidence interval; GTT, global thrombosis test; HR, hazard ratio; LMWH, low molecular weight heparin; LT, lysis time; MAC
Purification, characterization and in vivo studies of salmon heparin
Keywords: LMWH، هپارین با وزن مولکولی کم; APTT, activated partial thromboplastin time; GAG, glycosaminoglycan; EDC, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide; LMWH, low molecular weight heparin; MW, molecular weight; OPA, o-phtalaldehyde; Tris, tris(hydroxymethyl)aminomethane; U, units; VLMW
Antithrombotic Therapy in the Elderly
Keywords: LMWH، هپارین با وزن مولکولی کم; bleeding; coagulation; elderly; platelet; thrombosisACS, acute coronary syndrome; CAD, coronary artery disease; GP, glycoprotein; INR, international normalized ratio; LMWH, low molecular weight heparin; PCI, percutaneous coronary intervention; STEMI, ST-s
Perioperative Management of Patients With Drug-Eluting Stents
Keywords: LMWH، هپارین با وزن مولکولی کم; antiplatelet therapy; drug-eluting stent; noncardiac surgery; perioperative; stent thrombosisBMS, bare-metal stent(s); DES, drug-eluting stent(s); GP, glycoprotein; LMWH, low molecular weight heparin; MACE, major adverse cardiac events; PCI, percutaneous
Use of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial Infarction : A Report From the NCDR ACTION Registry–GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Ge
Keywords: LMWH، هپارین با وزن مولکولی کم; anticoagulants; bleeding; heparin; myocardial infarction; registriesACS, acute coronary syndrome(s); GP, glycoprotein; LMWH, low molecular weight heparin; NSTEMI, non–ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STE
Therapy for ST-Segment Elevation Myocardial Infarction Patients Who Present Late or Are Ineligible for Reperfusion Therapy
Keywords: LMWH، هپارین با وزن مولکولی کم; coronary artery disease; antithrombotic therapy; STEMIACEI, angiotensin-converting enzyme inhibitor; ACS, acute coronary syndrome; ASA, acetylsalicylic acid; CI, confidence interval; LMWH, low molecular weight heparin; MI, myocardial infarction; OR, odds
Attenuation effects of heparin–superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro
Keywords: LMWH، هپارین با وزن مولکولی کم; Cu,Zn-superoxide dismutase; Heparin–superoxide dismutase; Pulmonary fibrosis; Bleomycin; HydroxyprolineSOD, Cu,Zn-superoxide dismutase; LMWH, low molecular weight heparin; BLM, bleomycin; ROS, reactive oxygen species; IPF, idiopathic pulmonary fibrosis
Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation
Keywords: LMWH، هپارین با وزن مولکولی کم; DSC, differential scanning calorimetry; DVT, deep vein thrombosis; FTIR, Fourier transform infrared spectroscopy; CLSM, confocal laser scanning microscopy; LMWH, low molecular weight heparin; TER, transcutaneous electrical resistance; PBS, phosphate buffe
Efficacy of Low- molecular- weight- heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: A systematic review of randomized controlled trials
Keywords: LMWH، هپارین با وزن مولکولی کم; VTE, venous thromboembolism; DVT, deep venous thrombosis; PE, pulmonary embolism; LMWH, low molecular weight heparin; VKA, vitamin K antagonist; INR, international normalized ratio; CTPA, computed tomographic pulmonary angiography; US, ultrasound; V/Q sca
Use of Helical CT Is Associated with an Increased Incidence of Postoperative Pulmonary Emboli in Cancer Patients with No Change in the Number of Fatal Pulmonary Emboli
Keywords: LMWH، هپارین با وزن مولکولی کم; DVT, deep vein thrombosis; LMWH, low molecular weight heparin; MDCT, multidetector computed tomography; PE, pulmonary embolism; VTE, venous thromboembolic event
Development of a real-time PCR detection method for a FCGR2A polymorphism in the LightCycler and application in the heparin-induced thrombocytopenia syndrome
Keywords: LMWH، هپارین با وزن مولکولی کم; FCGR2A, Fc gamma receptor IIa; HIT, heparin-induced thrombocytopenia; HITT, heparin-induced thrombocytopenia and thrombosis; UFH, unfractionated heparin; LMWH, low molecular weight heparin; DVT, deep vein thrombosis; PE, pulmonary embolism; TECs, thromboe
Bleeding Events with Antithrombotic Therapy in Patients with Unstable Angina or non-ST-segment Elevation Myocardial Infarction; Insights from a Large Clinical Practice Registry (GRACE)
Keywords: LMWH، هپارین با وزن مولکولی کم; Acute coronary syndromes; Registry; Bleeding; Thienopyridines; Revascularisation; HeparinACS, acute coronary syndrome; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; LMWH, low molecular weight heparin
Elevated D-dimer concentration identifies patients with incomplete recanalization of pulmonary artery thromboemboli despite 6 months anticoagulation after the first episode of acute pulmonary embolism
Keywords: LMWH، هپارین با وزن مولکولی کم; APE, acute pulmonary embolism; CTEPH, chronic thromboembolic pulmonary hypertension; INR, international normalized ratio; LMWH, low molecular weight heparin; OAT, oral anticoagulant treatment; ROC, receiver operating curve; RVD, right ventricle dysfunctio
The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT
Keywords: LMWH، هپارین با وزن مولکولی کم; Thrombin generation; rhAPC; Melagatran; Calibrated automated thrombographyAPC, activated protein C; TG, thrombin generation; rhAPC, recombinant human activated protein C; VTE, venous thromboembolism; LMWH, low molecular weight heparin; UH, unfractionated
A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin)
Keywords: LMWH، هپارین با وزن مولکولی کم; Anti-FXa, anti-activated factor X (activity); APTT, activated partial thromboplastin time; BSL, beginning of shelf life; CV, coefficient of variation; ESL, end of shelf life; LMWH, low molecular weight heparin; OAT, oral anticoagulant treatment; PET, poly
Dose-escalation study of rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – for the prevention of venous thromboembolism in patients undergoing total hip replacement
Keywords: LMWH، هپارین با وزن مولکولی کم; VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism; LMWH, low molecular weight heparin; bid, twice daily; od, once daily; ITT, intention-to-treat; PP, per-protocol; ALT, alanine aminotransferase; AST, aspartate aminotransferase
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
Keywords: LMWH، هپارین با وزن مولکولی کم; UFH, unfractionated heparin; LMWH, low molecular weight heparin; VTE, venous thromboembolism; Adm, admitting diagnosisAnticoagulants; Knowledge translation; Medical patients; Prevention; Venous thromboembolism